Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1973 1
1974 2
1979 1
1980 1
1982 1
1983 3
1984 1
1985 2
1986 1
1987 1
1988 2
1990 5
1991 6
1992 4
1993 2
1994 5
1995 3
1996 8
1997 6
1998 3
1999 6
2000 8
2001 7
2002 7
2003 10
2004 11
2005 13
2006 8
2007 24
2008 12
2009 26
2010 17
2011 22
2012 19
2013 21
2014 31
2015 31
2016 27
2017 31
2018 30
2019 29
2020 31
2021 41
2022 44
2023 43
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

571 results

Results by year

Filters applied: . Clear all
Page 1
Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response.
Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, D'Offizi G, Prado MG, Trionfetti F, Vescovo T, Tartaglia E, Strippoli R, Agrati C, Tripodi M. Montaldo C, et al. J Hepatol. 2021 Dec;75(6):1301-1311. doi: 10.1016/j.jhep.2021.07.003. Epub 2021 Jul 13. J Hepatol. 2021. PMID: 34271004 Free article.
EVs purified from plasma of 17 HDs and 23 HCV-infected patients (T0 and T6) were employed for proteomic and western blot analyses. Functional analysis in LX2 cells measured fibrotic markers (mRNAs and proteins) in response to EVs. Structural analysis was performed by qPCR, …
EVs purified from plasma of 17 HDs and 23 HCV-infected patients (T0 and T6) were employed for proteomic and western blot analyses. Functiona …
RNA modifications in hematological malignancies.
Jin Z, MacPherson K, Liu Z, Vu LP. Jin Z, et al. Int J Hematol. 2023 Jun;117(6):807-820. doi: 10.1007/s12185-023-03576-0. Epub 2023 Mar 16. Int J Hematol. 2023. PMID: 36929506 Review.
With development of enabling technologies to identify and map RNA modifications, tremendous advancement has been made in our understanding of the biological functions of these molecular markers in diverse cellular contexts. In the last 5 years, N(6)-methyladenosine (m(6)A) …
With development of enabling technologies to identify and map RNA modifications, tremendous advancement has been made in our understanding o …
Glycosylation Changes in Cancer.
Bellis SL, Reis CA, Varki A, Kannagi R, Stanley P. Bellis SL, et al. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Mohnen D, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH, editors. Essentials of Glycobiology [Internet]. 4th edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022. Chapter 47. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Mohnen D, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH, editors. Essentials of Glycobiology [Internet]. 4th edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022. Chapter 47. PMID: 35536930 Free Books & Documents. Review.
Altered glycosylation is a universal feature of cancer cells, and certain glycans are well-known markers of tumor progression. This chapter discusses glycan biosynthetic pathways that are altered in cancer cells; correlations between altered glycosylation, diagnosis, and c …
Altered glycosylation is a universal feature of cancer cells, and certain glycans are well-known markers of tumor progression. This c …
Flow cytometric analysis of innate lymphoid cells: challenges and solutions.
Sadeghalvad M, Khijakadze D, Orangi M, Takei F. Sadeghalvad M, et al. Front Immunol. 2023 Sep 22;14:1198310. doi: 10.3389/fimmu.2023.1198310. eCollection 2023. Front Immunol. 2023. PMID: 37809100 Free PMC article. Review.
METHOD: We have designed combinations of cell surface markers to identify ILC populations in various tissues of B6 mice by flow cytometry. To minimize T cell contamination, TCR/CD3 antibodies were used separately from the Lin cocktail. ILCs identified by surface markers …
METHOD: We have designed combinations of cell surface markers to identify ILC populations in various tissues of B6 mice by flow cytom …
Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period.
Vasileiou K, Barnett J, Thorpe S, Young T. Vasileiou K, et al. BMC Med Res Methodol. 2018 Nov 21;18(1):148. doi: 10.1186/s12874-018-0594-7. BMC Med Res Methodol. 2018. PMID: 30463515 Free PMC article.
That sample size principles, guidelines and tools have been developed to enable researchers to set, and justify the acceptability of, their sample size is an indication that the issue constitutes an important marker of the quality of qualitative research. Nevertheless, res …
That sample size principles, guidelines and tools have been developed to enable researchers to set, and justify the acceptability of, their …
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future.
Yip TC, Lyu F, Lin H, Li G, Yuen PC, Wong VW, Wong GL. Yip TC, et al. Clin Mol Hepatol. 2023 Feb;29(Suppl):S171-S183. doi: 10.3350/cmh.2022.0426. Epub 2022 Dec 12. Clin Mol Hepatol. 2023. PMID: 36503204 Free PMC article. Review.
Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver biochemical markers. Liver histology keeps its role as the standard tool, yet it is well-known for substantial sampling, intraobserver, and inte …
Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver biochemical …
Gamete-competition models.
Sinsheimer JS, Blangero J, Lange K. Sinsheimer JS, et al. Am J Hum Genet. 2000 Mar;66(3):1168-72. doi: 10.1086/302826. Am J Hum Genet. 2000. PMID: 10712230 Free PMC article.
The gamete-competition model is an application of the Bradley-Terry model for ranking of sports teams. If allele i of a marker locus is assigned parameter taui>0, then the probability that a parent with heterozygous genotype i/j transmits allele i is Pr(i/j--> …
The gamete-competition model is an application of the Bradley-Terry model for ranking of sports teams. If allele i of a marker …
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Bolithon A, Popovic G, Leung B, Tang K, Lambie N, Millstein J, Alsop J, Anglesio MS, Ataseven B, Barlow E, Beckmann MW, Berger J, Bisinotto C, Bösmüller H, Boros J, Brand AH, Brooks-Wilson A, Brucker SY, Carney ME, Casablanca Y, Cazorla-Jiménez A, Cohen PA, Conrads TP, Cook LS, Coulson P, Courtney-Brooks M, Cramer DW, Crowe P, Cunningham JM, Cybulski C, Darcy KM, El-Bahrawy MA, Elishaev E, Erber R, Farrell R, Fereday S, Fischer A, García MJ, Gayther SA, Gentry-Maharaj A, Gilks CB; AOCS Group; Grube M, Harnett PR, Harrington SP, Harter P, Hartmann A, Hecht JL, Heikaus S, Hein A, Heitz F, Hendley J, Hernandez BY, Polo SH, Heublein S, Hirasawa A, Høgdall E, Høgdall CK, Horlings HM, Huntsman DG, Huzarski T, Jewell A, Jimenez-Linan M, Jones ME, Kaufmann SH, Kennedy CJ, Khabele D, Kommoss FKF, Kruitwagen RFPM, Lambrechts D, Le ND, Lener M, Lester J, Leung Y, Linder A, Loverix L, Lubiński J, Madan R, Maxwell GL, Modugno F, Neuhausen SL, Olawaiye A, Olbrecht S, Orsulic S, Palacios J, Pearce CL, Pike MC, Quinn CM, Mohan GR, Rodríguez-Antona C, Ruebner M, Ryan A, Salfinger SG, Sasamoto N, Schildkraut JM, Sch… See abstract for full author list ➔ Kang EY, et al. Cancer. 2023 Mar 1;129(5):697-713. doi: 10.1002/cncr.34582. Epub 2022 Dec 26. Cancer. 2023. PMID: 36572991 Free PMC article.
BACKGROUND: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). ...
BACKGROUND: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HG …
571 results